Return

Скрытая кровь в кале, ИХГА

Code:6007

Analysis details

Methodology

Expected Turnaround Time

1 day

Special Instructions

  • For 72 hours before collection, avoid meat, fish, green vegetables, and tomatoes.
  • For 72 hours before collection, do not use laxatives, rectal suppositories, or oils; avoid agents that affect gut motility (e.g., belladonna, pilocarpine) or change stool color (iron, bismuth, barium sulfate).
  • Collect the specimen before sigmoidoscopy and other diagnostic procedures involving the stomach or intestines.

How to use

The fecal occult blood test (FOBT), also known as an occult blood test or the benzidine test (Gregersen reaction), assesses stool for trace amounts of blood not visible on inspection. The assay supports evaluation of gastrointestinal mucosal injury due to peptic ulcer disease, primary or metastatic tumors of the esophagus, stomach, small or large intestine, inflammatory bowel disease, intestinal tuberculosis, and helminthiasis. It is used to estimate the extent of mucosal damage, to monitor response to therapy in conditions such as peptic ulcer disease, ulcerative colitis, Crohn disease, and intestinal tuberculosis, and to help gauge overall disease severity and prognosis.

Limitations

Occult gastrointestinal bleeding may accompany a wide spectrum of disorders and can be difficult or impossible to identify visually or by routine microscopy. When bleeding is brisk and arises from the lower gastrointestinal tract, bright red blood or clots may be evident; bleeding from the upper tract often produces black, tarry stools due to digestion of hemoglobin. In milder or intermittent bleeding, stool appearance remains normal, and intact erythrocytes may be sparse or absent microscopically. FOBT detects chemically altered hemoglobin rather than intact red cells, enabling identification of small-volume blood loss. A positive FOBT indicates mucosal disruption with blood loss into the gastrointestinal lumen and is observed in conditions such as peptic ulcer disease, ulcerative colitis, Crohn disease, intestinal polyps, helminthic invasion, and primary or metastatic gastrointestinal tumors. The test contributes to early detection of colorectal neoplasia, for which occult bleeding frequently begins at an early stage. Extraintestinal or proximal sources of blood—epistaxis, gingival or pharyngeal bleeding, esophageal varices, erosive esophagitis, and hemorrhoids—can also yield positive results and should be considered during interpretation. Analytical yield improves with repeat testing. A negative result does not exclude erosive, ulcerative, or neoplastic disease and must be interpreted alongside clinical assessment and other laboratory and imaging studies. The Gregersen (benzidine) reaction is a commonly used method for detecting occult blood in stool, but it is one of several methodologies available for fecal occult blood testing.

Reference interval
IndicationsUnexplained abdominal pain with dyspepsia, pyrosis, nausea, or vomiting, Altered bowel habits, including frequent loose stools, constipation, or tenesmus, with or without abdominal pain, Systemic features suggestive of gastrointestinal disease, such as unintended weight loss, anorexia, or fever, Documented gastrointestinal neoplasms by imaging or endoscopy to evaluate for occult gastrointestinal bleeding, Confirmed helminth infection to assess mucosal injury and bleeding risk, History of disorders associated with mucosal ulceration or inflammation, including peptic ulcer disease, ulcerative colitis, Crohn disease, intestinal tuberculosis, or intestinal polyposis

Specimen Requirements

SpecimenStool
ContainerSterile Stool Container